547 related articles for article (PubMed ID: 28800458)
1. Quinoline hybrids and their antiplasmodial and antimalarial activities.
Hu YQ; Gao C; Zhang S; Xu L; Xu Z; Feng LS; Wu X; Zhao F
Eur J Med Chem; 2017 Oct; 139():22-47. PubMed ID: 28800458
[TBL] [Abstract][Full Text] [Related]
2. Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic Application.
Joshi MC; Egan TJ
Curr Top Med Chem; 2020; 20(8):617-697. PubMed ID: 31985377
[TBL] [Abstract][Full Text] [Related]
3. Quinoline-based antimalarial hybrid compounds.
Vandekerckhove S; D'hooghe M
Bioorg Med Chem; 2015 Aug; 23(16):5098-119. PubMed ID: 25593097
[TBL] [Abstract][Full Text] [Related]
4. Hybrid molecules with potential in vitro antiplasmodial and in vivo antimalarial activity against drug-resistant Plasmodium falciparum.
Feng LS; Xu Z; Chang L; Li C; Yan XF; Gao C; Ding C; Zhao F; Shi F; Wu X
Med Res Rev; 2020 May; 40(3):931-971. PubMed ID: 31692025
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antiplasmodial activity of ferrocenyl aminoquinoline derivatives.
Mwande Maguene G; Lekana-Douki JB; Mouray E; Bousquet T; Grellier P; Pellegrini S; Toure Ndouo FS; Lebibi J; Pélinski L
Eur J Med Chem; 2015 Jan; 90():519-25. PubMed ID: 25486423
[TBL] [Abstract][Full Text] [Related]
6. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum.
Boechat N; Ferreira Mde L; Pinheiro LC; Jesus AM; Leite MM; Júnior CC; Aguiar AC; de Andrade IM; Krettli AU
Chem Biol Drug Des; 2014 Sep; 84(3):325-32. PubMed ID: 24803084
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Antiplasmodial Potential of C2 and C8 Modified Quinolines: in vitro and in silico Study.
Kumar R; Sharma R; Kumar I; Upadhyay P; Dhiman AK; Kumar R; Kumar R; Purohit R; Sahal D; Sharma U
Med Chem; 2019; 15(7):790-800. PubMed ID: 30324888
[TBL] [Abstract][Full Text] [Related]
8. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of new diaryl ether and quinoline hybrids as potential antiplasmodial and antimicrobial agents.
Mishra A; Batchu H; Srivastava K; Singh P; Shukla PK; Batra S
Bioorg Med Chem Lett; 2014 Apr; 24(7):1719-23. PubMed ID: 24630564
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors.
Kayamba F; Malimabe T; Ademola IK; Pooe OJ; Kushwaha ND; Mahlalela M; van Zyl RL; Gordon M; Mudau PT; Zininga T; Shonhai A; Nyamori VO; Karpoormath R
Eur J Med Chem; 2021 May; 217():113330. PubMed ID: 33744688
[TBL] [Abstract][Full Text] [Related]
11. New pentasubstituted pyrrole hybrid atorvastatin-quinoline derivatives with antiplasmodial activity.
Carvalho RC; Martins WA; Silva TP; Kaiser CR; Bastos MM; Pinheiro LC; Krettli AU; Boechat N
Bioorg Med Chem Lett; 2016 Apr; 26(8):1881-4. PubMed ID: 26988303
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, Antimalarial Activity and Docking Study of 7-Chloro-4- (2-(substituted benzylidene)hydrazineyl)quinolines.
Kalita J; Chetia D; Rudrapal M
Med Chem; 2020; 16(7):928-937. PubMed ID: 31385774
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, antiplasmodial activity and mechanistic studies of pyrimidine-5-carbonitrile and quinoline hybrids.
Kaur H; Balzarini J; de Kock C; Smith PJ; Chibale K; Singh K
Eur J Med Chem; 2015 Aug; 101():52-62. PubMed ID: 26114811
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of mono- and bisquinoline methanamine derivatives as potential antiplasmodial agents.
Bokosi FRB; Beteck RM; Mbaba M; Mtshare TE; Laming D; Hoppe HC; Khanye SD
Bioorg Med Chem Lett; 2021 Apr; 38():127855. PubMed ID: 33609655
[TBL] [Abstract][Full Text] [Related]
15. Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies.
Singh A; Kalamuddin M; Maqbool M; Mohmmed A; Malhotra P; Hoda N
Bioorg Chem; 2021 Mar; 108():104514. PubMed ID: 33280833
[TBL] [Abstract][Full Text] [Related]
16. 2,3,8-Trisubstituted Quinolines with Antimalarial Activity.
Martinez PDG; Krake SH; Poggi ML; Campbell SF; Willis PA; Dias LC
An Acad Bras Cienc; 2018; 90(1 Suppl 2):1215-1231. PubMed ID: 29791525
[TBL] [Abstract][Full Text] [Related]
17. Current scenario of ferrocene-containing hybrids for antimalarial activity.
Xiao J; Sun Z; Kong F; Gao F
Eur J Med Chem; 2020 Jan; 185():111791. PubMed ID: 31669852
[TBL] [Abstract][Full Text] [Related]
18. New Potential Antimalarial Agents: Design, Synthesis and Biological Evaluation of Some Novel Quinoline Derivatives as Antimalarial Agents.
Radini IA; Elsheikh TM; El-Telbani EM; Khidre RE
Molecules; 2016 Jul; 21(7):. PubMed ID: 27428939
[TBL] [Abstract][Full Text] [Related]
19. Quinolin-4(1H)-imines are potent antiplasmodial drugs targeting the liver stage of malaria.
Rodrigues T; da Cruz FP; Lafuente-Monasterio MJ; Gonçalves D; Ressurreição AS; Sitoe AR; Bronze MR; Gut J; Schneider G; Mota MM; Rosenthal PJ; Prudêncio M; Gamo FJ; Lopes F; Moreira R
J Med Chem; 2013 Jun; 56(11):4811-5. PubMed ID: 23701465
[TBL] [Abstract][Full Text] [Related]
20. New derivatives of quinoline-4-carboxylic acid with antiplasmodial activity.
Hochegger P; Faist J; Seebacher W; Saf R; Mäser P; Kaiser M; Weis R
Bioorg Med Chem; 2017 Apr; 25(7):2251-2259. PubMed ID: 28279559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
